1. Home
  2. ABCL vs TXO Comparison

ABCL vs TXO Comparison

Compare ABCL & TXO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ABCL
  • TXO
  • Stock Information
  • Founded
  • ABCL 2012
  • TXO 2012
  • Country
  • ABCL Canada
  • TXO United States
  • Employees
  • ABCL N/A
  • TXO N/A
  • Industry
  • ABCL Biotechnology: Pharmaceutical Preparations
  • TXO Oil & Gas Production
  • Sector
  • ABCL Health Care
  • TXO Energy
  • Exchange
  • ABCL Nasdaq
  • TXO Nasdaq
  • Market Cap
  • ABCL 818.2M
  • TXO 810.9M
  • IPO Year
  • ABCL 2020
  • TXO 2023
  • Fundamental
  • Price
  • ABCL $3.03
  • TXO $19.83
  • Analyst Decision
  • ABCL Buy
  • TXO
  • Analyst Count
  • ABCL 3
  • TXO 0
  • Target Price
  • ABCL $8.00
  • TXO N/A
  • AVG Volume (30 Days)
  • ABCL 3.9M
  • TXO 99.9K
  • Earning Date
  • ABCL 02-27-2025
  • TXO 03-04-2025
  • Dividend Yield
  • ABCL N/A
  • TXO 12.01%
  • EPS Growth
  • ABCL N/A
  • TXO N/A
  • EPS
  • ABCL N/A
  • TXO N/A
  • Revenue
  • ABCL $32,962,000.00
  • TXO $285,451,000.00
  • Revenue This Year
  • ABCL N/A
  • TXO N/A
  • Revenue Next Year
  • ABCL $37.26
  • TXO $32.37
  • P/E Ratio
  • ABCL N/A
  • TXO N/A
  • Revenue Growth
  • ABCL N/A
  • TXO N/A
  • 52 Week Low
  • ABCL $2.34
  • TXO $15.22
  • 52 Week High
  • ABCL $5.26
  • TXO $23.56
  • Technical
  • Relative Strength Index (RSI)
  • ABCL 45.64
  • TXO 65.96
  • Support Level
  • ABCL $2.88
  • TXO $19.38
  • Resistance Level
  • ABCL $3.60
  • TXO $20.70
  • Average True Range (ATR)
  • ABCL 0.20
  • TXO 0.61
  • MACD
  • ABCL -0.01
  • TXO 0.04
  • Stochastic Oscillator
  • ABCL 20.83
  • TXO 64.49

About ABCL AbCellera Biologics Inc.

AbCellera Biologics Inc is an antibody discovery and development engine that's specifically designed to address the barriers of conventional discovery, finding the optimal clinical candidate with greater precision and speed, getting to the clinic and patients sooner. With the integrated AbCellera platform, the company's experts search a wide range of diverse antibodies to select the effective and developable leads fast and set partners up for enduring success. The company have extensive experience forging partnerships with emerging biotechs and pharmaceutical companies. AbCellera leverages proprietary hardware, software, and tools along with the latest data science, to operate as strategic partners and help develop optimized solutions faster for any program.

About TXO TXO Partners L.P.

TXO Partners LP is focused on the acquisition, development, optimization and exploitation of oil, natural gas, and natural gas liquid reserves in North America.

Share on Social Networks: